Zenosense
is a company on a mission. The emerging healthcare technology company has
undertaken the challenge of developing functioning yet cost-effective medical
devices that will detect, early on, deadly bacteria and certain cancers in a
patient’s exhaled breath.
The
company currently has two devices under development:
• a device intended to detect lung
cancer
• a device intended to detect the
Methicillin-resistant Staphylococcus aureus “Super-Bug” (MRSA)
The
process of developing the lung cancer detection device has been interesting
lately. This past November, Zenosense revealed plans to manufacture a pre-market
prototype device that will eventually be evaluated during a lung cancer
detection trial in a clinical setting.
Zenon
Biosystem, Zenosense’s contracted development partner and a member company of
the Sgenia Group, has undertaken the task of manufacturing the prototype. In
preparation for the expected lung cancer detection trial and in accordance with
the protocol design for the trial, Zenon will manufacture two pre-commercial
devices of identical design to ensure that trial results can be replicated.
The
device will be designed using an Electronic Nose technology platform. It will
incorporate components capable of filtering out Volatile Organic Compounds
(VOCs) that are not of interest in order to improve the detection of specific
VOC biomarkers found in exhaled breath and linked to the incidence of lung
cancer. In keeping with its mission, Zenosense means to use components of a
relatively low cost to create this product cost-effectively.
Zenon
is hard at work establishing the necessary collaborations needed to carry out
the planned lung cancer detection trial, and Zenosense is eagerly anticipating
the testing of the prototype in the trial. Zenosense believes a cost-effective,
breath-analyzing lung cancer detector that is proven to meet or, better yet, exceed
the accuracy of low-dose Computed Tomography (CT) scanning will generate wide
appeal and, subsequently, substantial demand.
For
more information, visit the company’s website at www.zenosense.net
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
Sign
up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The
Quality Stocks Daily Blog http://blog.qualitystocks.net
The
Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The
Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
No comments:
Post a Comment